Larry L. Wood, President and CEO of PROCEPT BioRobotics Corp (NASDAQ: PRCT), filed a Form 4 on August 7, 2026, reporting the purchase of 23,900 shares of common stock through The Larry Wood Trust.

Key Highlights

  • Purchase date: The transaction was dated August 7, 2026.
  • Shares acquired: 23,900 shares of common stock were acquired (transaction code P) through The Larry Wood Trust.
  • Weighted average price: The shares were purchased at a weighted average price of $20.85, with individual transaction prices ranging from $20.67 to $21.02, inclusive.
  • Post-transaction indirect holdings: Following the purchase, The Larry Wood Trust holds 23,900 shares indirectly.
  • Direct beneficial ownership: Wood also holds 314,203 shares directly, which the filing notes includes 825 shares acquired on May 14, 2026, under the issuer's 2021 Employee Stock Purchase Plan.
  • Reporting person's role: Wood is identified as both a Director and Officer (President, CEO) of PROCEPT BioRobotics Corp.

Details of Larry Wood's Common Stock Purchase at PROCEPT BioRobotics

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Larry L. Wood, serving as President and CEO of PROCEPT BioRobotics Corp, reported a purchase of 23,900 shares of the company's common stock on August 7, 2026. The filing discloses that the shares were acquired indirectly through The Larry Wood Trust at a weighted average price of $20.85 per share. The filing further notes that the purchase was executed across multiple transactions at prices ranging from $20.67 to $21.02, inclusive, and that Wood undertakes to provide full details of shares purchased at each separate price upon request.

In addition to the indirectly held shares reported in this transaction, the filing shows Wood directly owns 314,203 shares of common stock following the reported transactions. The filing notes that this direct holdings figure includes 825 shares acquired on May 14, 2026, under the issuer's 2021 Employee Stock Purchase Plan. The Form 4 was signed by Jonathan Stone as Attorney-in-Fact for Larry Wood on August 7, 2026.

No derivative securities transactions were reported in this filing. The filing was submitted as an individual report by one reporting person and does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as the corresponding checkbox on the form was not checked.

What Was Disclosed

The filing reports that PROCEPT BioRobotics President and CEO Larry L. Wood acquired 23,900 shares of common stock indirectly through The Larry Wood Trust on August 7, 2026, at a weighted average price of $20.85 per share, with prices ranging from $20.67 to $21.02.